BackgroundCheck.run
Search For

Qin Jiang, 47Olive Branch, MS

Known as:
Jiang Qin
Related to:
Dong Jiang 53 Ai Cheng Jiang

Qin Jiang Phones & Addresses

Olive Branch, MS   

406 Casa Linda Dr, El Dorado, AR 71730   

Southaven, MS   

542 53Rd St, Brooklyn, NY 11220   

New York, NY   

Pittsburgh, PA   

Corbin, KY   

Education

School / High School: London School of Economics

Ranks

Licence: New York - Currently registered Date: 2006
Get Report
Control this profile

Mentions for Qin Jiang

Career records & work history

Lawyers & Attorneys

Qin Jiang Photo 1

Qin Jiang - Lawyer

Address:
Hogan Lovells International LLP
216-1223800 (Office)
Licenses:
New York - Currently registered 2006
Education:
London School of Economics
Boston University School of Law
Qin Jiang Photo 2

Qin Jiang - Lawyer

ISLN:
924303042
Admitted:
2006

Medicine Doctors

Qin Li Jiang

Specialties:
Neurology
Work:
University Of Illinois At Chicago Neuro Rehabilitation Center
1801 W Taylor St STE 4E, Chicago, IL 60612
312-9966496 (phone) 312-9964169 (fax)
Jesse Brown VA Medical Center Neurology
820 S Damen Ave RM 2354, Chicago, IL 60612
312-5698387 (phone)
Education:
Medical School
Medical University of South Carolina College of Medicine
Graduated: 2003
Procedures:
Neurological Testing, Pulmonary Function Tests, Sleep and EEG Testing
Conditions:
Epilepsy, Multiple Sclerosis (MS), Myasthenia Gravis (MG), Peripheral Nerve Disorders, Dementia, Hemorrhagic stroke, Ischemic Stroke, Migraine Headache, Parkinson's Disease, Transient Cerebral Ischemia
Languages:
English, Spanish
Description:
Dr. Jiang graduated from the Medical University of South Carolina College of Medicine in 2003. She works in Chicago, IL and 1 other location and specializes in Neurology. Dr. Jiang is affiliated with University Of Illinois Hospital Health & Science Center.

Resumes & CV records

Resumes

Qin Jiang Photo 34

Qin Jiang

Qin Jiang Photo 35

Qin Jiang

Work:
Shanghai Meteorological Service
Qin Jiang Photo 36

Qin Jiang

Location:
United States

Publications & IP owners

Wikipedia

Qin Jiang Photo 38

Jiang Qin

Jiang Qin (died 219), style name Gongyi (), was a military general serving under the warlord Sun Quan during the late Han Dynasty period of Chinese history.

Us Patents

Methods And Compositions For The Diagnosis And Treatment Of Cancer Resistant To Anaplastic Lymphoma Kinase (Alk) Kinase Inhibitors

US Patent:
8383793, Feb 26, 2013
Filed:
Apr 15, 2010
Appl. No.:
12/761050
Inventors:
Stephan W. Morris - Germantown TN, US
Qin Jiang - Memphis TN, US
Xiaoli Cui - Memphis TN, US
Liquan Xue - Cordova TN, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
C07H 21/04
C12N 15/00
US Classification:
536 231, 435 691
Abstract:
Compositions and methods for the diagnosis and treatment of a cancer that is resistant to at least one anaplastic lymphoma kinase (ALK) kinase inhibitor are provided herein. The present invention is based on the discovery of mutations within ALK that confer resistance to at least one ALK kinase inhibitor. Polynucleotides and polypeptides having at least one ALK inhibitor resistance mutation are provided and find use in methods and compositions useful in the diagnosis, prognosis, and/or treatment of diseases associated with aberrant ALK activity, more particularly, those that are resistant to at least one ALK kinase inhibitors. Methods and compositions are also provided for the identification of agents that can inhibit the kinase activity and/or reduce the expression level of the ALK resistance mutants.

Methods And Compositions For The Diagnosis And Treatment Of Cancer Resistant To Anaplastic Lymphoma Kinase (Alk) Kinase Inhibitors

US Patent:
2013024, Sep 19, 2013
Filed:
Feb 20, 2013
Appl. No.:
13/771948
Inventors:
Stephen W. Morris - Germantown TN, US
Qin Jiang - Memphis TN, US
Xiaoli Cui - Memphis TN, US
Liquan Xue - Cordova TN, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
International Classification:
C12Q 1/68
C12N 9/12
US Classification:
506 9, 536 232, 4353201, 536 2431, 435 611
Abstract:
Compositions and methods for the diagnosis and treatment of a cancer that is resistant to at least one anaplastic lymphoma kinase (ALK) kinase inhibitor are provided herein. The present invention is based on the discovery of mutations within ALK that confer resistance to at least one ALK kinase inhibitor. Polynucleotides and polypeptides having at least one ALK inhibitor resistance mutation are provided and find use in methods and compositions useful in the diagnosis, prognosis, and/or treatment of diseases associated with aberrant ALK activity, more particularly, those that are resistant to at least one ALK kinase inhibitors. Methods and compositions are also provided for the identification of agents that can inhibit the kinase activity and/or reduce the expression level of the ALK resistance mutants.

Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment

US Patent:
2023010, Apr 6, 2023
Filed:
Jun 27, 2022
Appl. No.:
17/850144
Inventors:
- Baltimore MD, US
John A. Butera - Clarksburg NJ, US
Jianxing Huang - Bethlehem PA, US
Hemantbhai Patel - Piscataway NJ, US
Qin Jiang - Latham NY, US
Robert Jason Herr - Voorheesville NY, US
Emily Elizabeth Freeman - Voorheesville NY, US
Nicholas James Mayhew - Niskayuna NY, US
International Classification:
C07D 487/14
A61P 25/28
A61P 25/18
A61P 25/16
Abstract:
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer's Disease (AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.

Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment

US Patent:
2023009, Mar 30, 2023
Filed:
Dec 18, 2020
Appl. No.:
17/786175
Inventors:
- Baltimore MD, US
John A. Butera - Clarksburg NJ, US
Jianxing Huang - Bethlehem PA, US
Hemantbhai Patel - Piscataway NJ, US
Qin Jiang - Latham NY, US
Robert Jason Herr - Voorheesville NY, US
Emily Elizabeth Freeman - Voorheesville NY, US
Nicholas James Mayhew - Niskayuna NY, US
International Classification:
A61K 31/5517
C07D 487/14
A61K 31/496
A61K 31/5513
A61K 31/13
A61K 31/445
A61K 31/55
A61K 31/27
A61P 25/28
Abstract:
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an α5-containing GABAreceptor agonist (e.g, an α5-containing GABAreceptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer's Disease (AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.

Benzodiazepine Derivatives, Compositions, And Methods For Treating Cognitive Impairment

US Patent:
2020004, Feb 13, 2020
Filed:
Jun 19, 2019
Appl. No.:
16/445854
Inventors:
- Baltimore MD, US
John A. Butera - Clarksburg NJ, US
Jianxing Huang - Bethlehem PA, US
Hemantbhai Patel - Piscataway NJ, US
Qin Jiang - Latham NY, US
Robert Jason Herr - Voorheesville NY, US
Emily Elizabeth Freeman - Voorheesville NY, US
Nicholas James Mayhew - Niskayuna NY, US
International Classification:
C07D 487/14
A61P 25/16
A61P 25/28
A61P 25/18
Abstract:
This invention relates to benzodiazepine derivatives, compositions comprising therapeutically effective amounts of those derivatives and methods of using those derivatives or compositions in treating cognitive impairment associated with CNS disorders. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating cognitive impairment associated with CNS disorders in a subject in need or at risk thereof, including age-related cognitive impairment, Mild Cognitive Impairment (MCI), amnestic MCI, Age-Associated Memory Impairment, Age Related Cognitive Decline, dementia, Alzheimer's Disease (AD), prodromal AD, PTSD, schizophrenia, bipolar disorder, ALS, cancer-therapy-related cognitive impairment, mental retardation, Parkinson's disease, autism spectrum disorders, fragile X disorder, Rett syndrome, compulsive behavior, and substance addiction. It also relates to the use of an α5-containing GABAreceptor agonist (e.g., an α5-containing GABAreceptor positive allosteric modulator) in treating brain cancers (including brain tumors, e.g., medulloblastomas), and cognitive impairment associated therewith.

Possible Relatives

Cynthia Jiang  David Q Jiang  Daniel X Jiang  Danny P Jiang  Dennis Jiang  Dian Jiang  Dongyan Jiang  Qin G Li  Qin Lin  Qin E Liu 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.